Search research articles
Contact Us
Filters
Showing results (131-140 of 136) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 136 results.
Plos One
|
April 27, 2010
Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate
J Brian de Souza, Uduak Okomo, Neal D Alexander, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
Brima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
Iscience
|
December 27, 2021
Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19
Julie C Wilson, David Kealy, Sally R James, et al.
Molecular Therapy. Methods & Clinical Development
|
September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis
Brima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Nature Communications
|
March 11, 2025
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19
Jimmy Tsz Hang Lee, Sam N Barnett, Kenny Roberts, et al.
Plos Neglected Tropical Diseases
|
February 27, 2026
Systemic inflammatory markers of visceral leishmaniasis treatment response in East Africa
Ayenew Addisu, Alice Bayiyana, João L Reis Cunha, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 136) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 136 results.
Plos One
|
April 27, 2010
Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate
J Brian de Souza, Uduak Okomo, Neal D Alexander, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 30, 2021
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
Brima M Younis, Mohamed Osman, Eltahir A G Khalil, et al.
Iscience
|
December 27, 2021
Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19
Julie C Wilson, David Kealy, Sally R James, et al.
Molecular Therapy. Methods & Clinical Development
|
September 10, 2024
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis
Brima M Younis, Rebecca Wiggins, Eltahir A G Khalil, et al.
Nature Communications
|
March 11, 2025
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19
Jimmy Tsz Hang Lee, Sam N Barnett, Kenny Roberts, et al.
Plos Neglected Tropical Diseases
|
February 27, 2026
Systemic inflammatory markers of visceral leishmaniasis treatment response in East Africa
Ayenew Addisu, Alice Bayiyana, João L Reis Cunha, et al.
Page
of 14